Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+8.26%
|
$0
$0.46 P/Share
|
|
Dec 12
2022
|
Catherine M. Szyman Director |
SELL
Bona fide gift
|
Direct |
16,000
-50.17%
|
-
|
|
Nov 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.32%
|
$740,000
$74.81 P/Share
|
|
Nov 21
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-3.79%
|
$693,000
$77.68 P/Share
|
|
Nov 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.22%
|
$560,000
$80.13 P/Share
|
|
Nov 15
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
55,000
-1.47%
|
$4,455,000
$81.61 P/Share
|
|
Nov 14
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-2.89%
|
$1,007,250
$79.19 P/Share
|
|
Nov 14
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+7.65%
|
$0
$0.46 P/Share
|
|
Oct 27
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.41%
|
$760,000
$76.21 P/Share
|
|
Oct 20
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.77%
|
$648,000
$72.63 P/Share
|
|
Oct 18
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.22%
|
$560,000
$80.07 P/Share
|
|
Oct 17
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
55,000
-1.21%
|
$4,125,000
$75.28 P/Share
|
|
Oct 14
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-1.61%
|
$943,500
$74.76 P/Share
|
|
Oct 14
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+7.12%
|
$0
$0.46 P/Share
|
|
Oct 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-0.32%
|
$49,248
$72.64 P/Share
|
|
Oct 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.38%
|
$71,496
$72.64 P/Share
|
|
Oct 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,420
-0.2%
|
$102,240
$72.64 P/Share
|
|
Oct 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-0.42%
|
$47,736
$72.64 P/Share
|
|
Sep 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.22%
|
$560,000
$80.25 P/Share
|
|
Sep 09
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
13,692
-1.27%
|
$1,040,592
$76.71 P/Share
|
|
Sep 08
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
16,308
-4.3%
|
$1,223,100
$75.12 P/Share
|
|
Sep 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.88%
|
$2,130,000
$71.25 P/Share
|
|
Sep 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.84%
|
$0
$0.43 P/Share
|
|
Sep 06
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-3.68%
|
$350,000
$70.0 P/Share
|
|
Aug 29
2022
|
William Hoffman Director |
SELL
Bona fide gift
|
Direct |
139,998
-26.98%
|
-
|
|
Aug 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.07%
|
$567,000
$81.46 P/Share
|
|
Aug 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.24%
|
$607,500
$81.85 P/Share
|
|
Aug 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.99%
|
$0
$0.46 P/Share
|
|
Aug 12
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-6.13%
|
-
|
|
Aug 05
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.11%
|
$2,460,000
$83.0 P/Share
|
|
Aug 05
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.18%
|
$0
$0.43 P/Share
|
|
Aug 02
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
21,000
-0.1%
|
$1,680,000
$80.74 P/Share
|
|
Aug 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.89%
|
$390,000
$78.47 P/Share
|
|
Jul 18
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
5,275
-1.01%
|
$395,625
$75.29 P/Share
|
|
Jul 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.95%
|
$540,000
$72.73 P/Share
|
|
Jul 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.99%
|
$0
$0.46 P/Share
|
|
Jul 08
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
11,237
-1.05%
|
$842,775
$75.58 P/Share
|
|
Jul 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
13,488
-2.46%
|
$1,011,600
$75.08 P/Share
|
|
Jul 06
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.75%
|
$2,160,000
$72.5 P/Share
|
|
Jul 06
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.93%
|
$0
$0.43 P/Share
|
|
Jul 05
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-3.42%
|
$350,000
$70.31 P/Share
|
|
Jul 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-0.32%
|
$46,512
$68.66 P/Share
|
|
Jul 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.34%
|
$67,524
$68.66 P/Share
|
|
Jul 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,408
-0.13%
|
$95,744
$68.66 P/Share
|
|
Jul 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-0.42%
|
$45,084
$68.66 P/Share
|
|
Jun 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.21%
|
$450,000
$60.49 P/Share
|
|
Jun 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.93%
|
$0
$0.46 P/Share
|
|
Jun 14
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-5.75%
|
-
|
|
Jun 07
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-3.29%
|
$350,000
$70.08 P/Share
|
|
Jun 06
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.74%
|
$2,010,000
$67.94 P/Share
|